Suchergebnisse - "Hu, Hengrui"

PubPharm (50)

1

Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants

enthalten in: bioRxiv.org | 2024

von Tan, S. | Hu, X. | Li, Y. | +29

2

Crucial role played by CK8+ cells in mediating alveolar injury remodeling for patients with COVID-19

enthalten in: Virologica Sinica | 2024

von Li, Y. | Hu, H. | Liu, J. | +10

3

Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants

enthalten in: Science bulletin | 2023

von Tan, S. | Zhao, J. | Hu, X. | +29

4

SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts

enthalten in: Stem cell research & therapy | 2023

von Li, X. | Hu, H. | Liu, W. | +8

5

SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts

enthalten in: Stem cell research & therapy | 2023

von Li, X. | Hu, H. | Liu, W. | +8

6

Integrated intelligent liquid food device

enthalten in: Europäisches Patentamt | 2023

von HU HENGRUI

7

Integrated intelligent liquid food device

enthalten in: Europäisches Patentamt | 2023

von HU HENGRUI

8

Construction and characterization of a synthesized herpes simplex virus H129-Syn-G2

enthalten in: Virologica Sinica | 2023

von Xiao, H. | Hu, H. | Guo, Y. | +6

9

Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo

enthalten in: Virologica Sinica | 2023

von Wang, Q. | Peng, L. | Nie, Y. | +16

10

Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro

enthalten in: Viruses | 2023

von Wang, X. | Burdzhiev, N. | Hu, H. | +5

1
2
3
4
5
Nächster »
[5]